Spectral AI, Inc. (MDAI)

US — Healthcare Sector
Peers: EDAP  LUNG  VANI  ICCM  CTSO  AEMD  ADAG  TELA  GANX  CAMP 

Automate Your Wheel Strategy on MDAI

With Tiblio's Option Bot, you can configure your own wheel strategy including MDAI - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.

Start Your Free Trial Now

Key Metrics & Ratings

  • symbol MDAI
  • Rev/Share 1.0837
  • Book/Share -0.36
  • PB -6.2227
  • Debt/Equity -1.0543
  • CurrentRatio 0.865
  • ROIC -23.7382

 

  • MktCap 59831876.0
  • FreeCF/Share -0.237
  • PFCF -9.9323
  • PE -3.9774
  • Debt/Assets 0.6027
  • DivYield 0
  • ROE 2.5607

 

  • Rating C
  • Score 2
  • Recommendation Sell
  • P/E Score 1
  • DCF Score 1
  • P/B Score 1
  • D/E Score 1

Recent Analyst Ratings

Type Ticker Analyst Firm Previous Rating Current Rating Previous Price Target Current Price Target Date
No ratings available.

News

Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
MDAI
Published: March 24, 2025 by: GlobeNewsWire
Sentiment: Neutral

DALLAS, March 24, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (NASDAQ: MDAI) ("Spectral AI" or the "Company"), a leading developer of the AI-driven DeepView® System, which uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the successful completion of a debt financing agreement of up to $15.0 million in funding from Avenue Venture Opportunities Fund II, L.P., a fund of Avenue Capital Group, with an initial draw down of $8.5 million. In connection with this debt financing, the Company also raised $2.7 million of equity financing from institutional as well as existing investors. With total cash …

Read More
image for news Spectral AI Raises up to $15 Million of Debt Financing and Strengthens Financial Position for U.S. Commercialization
Spectral AI Completes Three Device Installations in Australia
MDAI
Published: March 06, 2025 by: GlobeNewsWire
Sentiment: Neutral

DALLAS, March 06, 2025 (GLOBE NEWSWIRE) -- Spectral AI (NASDAQ: MDAI) (“Spectral AI” or the “Company”), developer of the AI-driven DeepView® System, which received Breakthrough Device Designation from the U.S. Food and Drug Administration (“FDA”) in 2018 and uses multi-spectral imaging and AI algorithms to predict burn healing potential, today announced the completion of the installation of three of the DeepView System devices in Australia. The Company, in partnership with global medical device company and burn wound therapy leader PolyNovo Limited (“PolyNovo”). The Company was able to utilize the Australian Special Access Scheme (SAS) to deploy three DeepView Systems at …

Read More
image for news Spectral AI Completes Three Device Installations in Australia

About Spectral AI, Inc. (MDAI)

  • IPO Date 2021-04-06
  • Website https://www.spectral-ai.com
  • Industry Medical - Devices
  • CEO Wensheng Fan
  • Employees 78

Spectral AI, Inc. operates as an artificial intelligence (AI) company. The company focuses on medical diagnostics for faster and accurate treatment decisions in wound care with applications involving patients with burns and diabetic foot ulcers. Its products include DeepView, a predictive diagnostic device that offers clinicians an objective and immediate assessment of a wound's healing potential prior to treatment or other medical intervention. The company is based in Dallas, Texas.